Clinical Trial Update: Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates the pharmacokinetics and optimal timing of initiating dronedarone after long-term amiodarone in patients with atrial fibrill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)
• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED